Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer


Autoria(s): Jeet, Varinder; Rockstroh, Anja; Lehman, Melanie; Nelson, Colleen C.
Data(s)

2015

Identificador

http://eprints.qut.edu.au/94785/

Publicador

Wiley-Blackwell Publishing Ltd.

Relação

DOI:10.1111/bju.13198

Jeet, Varinder, Rockstroh, Anja, Lehman, Melanie, & Nelson, Colleen C. (2015) Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.

Direitos

Copyright 2015 The Authors

Fonte

School of Biomedical Sciences; Faculty of Education; Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #111201 Cancer Cell Biology #111204 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) #prostate cancer #angiogenic target #YKL40 #metastasis #cancer treatment
Tipo

Conference Item